DFTX
Definium Therapeutics, Inc.Company with tickers: DFTX
CIK
1813814
CUSIP
24477V105
Shares Outstanding
109,066,783
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-25 | Karlin Daniel | Chief Medical Officer | Sell | 8,018 |
| 2026-03-25 | Sullivan Mark | General Counsel & Secretary | Sell | 10,702 |
| 2026-03-25 | Barrow Robert | Director, Chief Executive Officer | Sell | 24,431 |
| 2026-02-03 | Sullivan Mark | General Counsel & Secretary | Award | 125,000 |
| 2026-02-03 | Karlin Daniel | Chief Medical Officer | Award | 150,000 |
| 2026-02-03 | Roberts Brandi | Chief Financial Officer | Award | 150,000 |
| 2026-02-03 | Wiley Matthew T. | Chief Commercial Officer | Award | 115,000 |
| 2026-02-03 | Barrow Robert | Director, Chief Executive Officer | Award | 320,000 |
| 2026-01-29 | Adsett Roger | Chief Operating Officer | Award | 50,000 |
| 2026-01-29 | Adsett Roger | Chief Operating Officer | Other | 0 |
| 2025-12-26 | Karlin Daniel | Chief Medical Officer | Sell | 5,600 |
| 2025-12-26 | Barrow Robert | Director, Chief Executive Officer | Sell | 25,791 |
| 2025-12-26 | Sullivan Mark | General Counsel & Secretary | Sell | 11,276 |
| 2025-09-25 | Barrow Robert | Director, Chief Executive Officer | Sell | 25,797 |
| 2025-09-25 | Karlin Daniel | Chief Medical Officer | Sell | 7,704 |
| 2025-09-25 | Sullivan Mark | General Counsel & Secretary | Sell | 11,278 |
| 2025-06-25 | Sullivan Mark | General Counsel & Secretary | Sell | 11,491 |
| 2025-06-25 | Karlin Daniel | Chief Medical Officer | Sell | 7,848 |
| 2025-06-25 | Barrow Robert | Director, Chief Executive Officer | Sell | 26,491 |
| 2025-06-12 | GRYSKA DAVID W | Director | Award | 75,187 |
| 2025-06-12 | Vallone Carol A | Director | Award | 75,187 |
| 2025-06-12 | Bruhn Suzanne Louise | Director | Award | 75,187 |
| 2025-06-12 | Krebs Andreas | Director | Award | 75,187 |
| 2025-06-12 | CRYSTAL ROGER | Director | Award | 75,187 |
| 2025-06-02 | Roberts Brandi | Chief Financial Officer | Award | 500,000 |
| 2025-06-02 | Roberts Brandi | Chief Financial Officer | Other | 0 |
| 2025-03-25 | Barrow Robert | Director, Chief Executive Officer | Sell | 21,208 |
| 2025-03-25 | Karlin Daniel | Chief Medical Officer | Sell | 6,836 |
| 2025-03-25 | Sullivan Mark | General Counsel & Secretary | Sell | 6,576 |
| 2025-03-25 | Liao Carrie | Chief Accounting Officer | Sell | 2,347 |
| 2025-03-17 | Wiley Matthew T. | Chief Commercial Officer | Award | 350,000 |
| 2025-03-17 | Wiley Matthew T. | Chief Commercial Officer | Other | 0 |
| 2025-03-12 | Barrow Robert | Director, Chief Executive Officer | Award | 350,000 |
| 2025-03-12 | Karlin Daniel | Chief Medical Officer | Award | 115,000 |
| 2025-03-12 | Sullivan Mark | General Counsel & Secretary | Award | 150,000 |
| 2025-03-12 | Liao Carrie | Chief Accounting Officer | Award | 50,000 |
| 2024-12-26 | Barrow Robert | Director, Chief Executive Officer | Sell | 19,106 |
| 2024-12-26 | Liao Carrie | Chief Accounting Officer | Sell | 2,273 |
| 2024-12-26 | Karlin Daniel | Chief Medical Officer | Sell | 6,643 |
| 2024-12-26 | Sullivan Mark | General Counsel & Secretary | Sell | 4,519 |
| 2024-12-05 | GRYSKA DAVID W | Director | Buy | 2,500 |
| 2024-09-25 | Barrow Robert | Director, Chief Executive Officer | Sell | 19,771 |
| 2024-09-25 | Liao Carrie | Chief Accounting Officer | Sell | 2,352 |
| 2024-09-25 | Sullivan Mark | General Counsel & Secretary | Sell | 4,430 |
| 2024-09-25 | Karlin Daniel | Chief Medical Officer | Sell | 6,871 |
| 2024-08-23 | GRYSKA DAVID W | Director | Buy | 3,500 |
| 2024-08-21 | Halperin Wernli Miri | Executive President | Convert | 50,000 |
| 2024-08-21 | Halperin Wernli Miri | Executive President | Tax | 32,595 |
| 2024-08-21 | Halperin Wernli Miri | Executive President | Convert | 50,000 |
| 2024-08-20 | Barrow Robert | Director, Chief Executive Officer | Buy | 500 |
| 2024-08-19 | Barrow Robert | Director, Chief Executive Officer | Buy | 500 |
| 2024-06-25 | Barrow Robert | Director, Chief Executive Officer | Sell | 15,659 |
| 2024-06-25 | Sullivan Mark | General Counsel & Secretary | Sell | 17,854 |
| 2024-06-25 | Karlin Daniel | Chief Medical Officer | Sell | 6,925 |
| 2024-06-10 | Vallone Carol A | Director | Award | 16,506 |
| 2024-06-10 | Bruhn Suzanne Louise | Director | Award | 16,506 |
| 2024-06-10 | Krebs Andreas | Director | Award | 16,506 |
| 2024-06-10 | GRYSKA DAVID W | Director | Award | 16,506 |
| 2024-06-10 | CRYSTAL ROGER | Director | Award | 16,506 |
| 2024-03-25 | Greenway Schond L. | CFO | Tax | 5,560 |
| 2024-03-25 | Barrow Robert | Director, Chief Executive Officer | Sell | 16,519 |
| 2024-03-25 | Karlin Daniel | Chief Medical Officer | Sell | 6,578 |
| 2024-02-27 | Sullivan Mark | General Counsel & Secretary | Award | 125,000 |
| 2024-02-27 | Karlin Daniel | Chief Medical Officer | Award | 150,000 |
| 2024-02-27 | Liao Carrie | Chief Accounting Officer | Award | 100,000 |
| 2024-02-27 | Halperin Wernli Miri | Executive President | Award | 125,000 |
| 2024-02-27 | Greenway Schond L. | CFO | Award | 150,000 |
| 2024-02-27 | Barrow Robert | Director, Chief Executive Officer | Award | 400,000 |
| 2023-12-26 | Karlin Daniel | Chief Medical Officer | Sell | 6,774 |
| 2023-12-26 | Barrow Robert | Director, Chief Executive Officer | Sell | 13,237 |
| 2023-12-26 | Greenway Schond L. | CFO | Sell | 5,652 |
| 2023-09-25 | Barrow Robert | Director, Chief Executive Officer | Sell | 8,231 |
| 2023-09-25 | Barrow Robert | Director, Chief Executive Officer | Sell | 5,268 |
| 2023-09-25 | Karlin Daniel | Chief Medical Officer | Sell | 3,678 |
| 2023-09-25 | Karlin Daniel | Chief Medical Officer | Sell | 3,240 |
| 2023-09-25 | Greenway Schond L. | CFO | Sell | 1,908 |
| 2023-09-25 | Greenway Schond L. | CFO | Sell | 3,854 |
| 2023-08-25 | Greenway Schond L. | CFO | Sell | 20,000 |
| 2023-06-27 | Barrow Robert | Director, Chief Executive Officer | Sell | 7,086 |
| 2023-06-27 | Barrow Robert | Director, Chief Executive Officer | Sell | 8,416 |
| 2023-06-27 | Karlin Daniel | Chief Medical Officer | Sell | 3,820 |
| 2023-06-27 | Karlin Daniel | Chief Medical Officer | Sell | 2,963 |
| 2023-06-27 | Greenway Schond L. | CFO | Sell | 7,694 |
| 2023-06-27 | Greenway Schond L. | CFO | Sell | 3,941 |
| 2023-06-21 | Krebs Andreas | Director | Award | 19,203 |
| 2023-06-21 | CRYSTAL ROGER | Director | Award | 13,671 |
| 2023-06-21 | CRYSTAL ROGER | Director | Award | 19,203 |
| 2023-06-21 | Bruhn Suzanne Louise | Director | Award | 19,203 |
| 2023-06-21 | Bruhn Suzanne Louise | Director | Award | 13,671 |
| 2023-06-21 | GRYSKA DAVID W | Director | Award | 13,851 |
| 2023-06-21 | GRYSKA DAVID W | Director | Award | 13,131 |
| 2023-06-21 | GRYSKA DAVID W | Director | Award | 37,594 |
| 2023-06-21 | Vallone Carol A | Director | Award | 13,671 |
| 2023-06-21 | Vallone Carol A | Director | Award | 19,203 |
| 2023-06-21 | GRYSKA DAVID W | Director | Other | 0 |
| 2023-06-21 | Krebs Andreas | Director | Award | 13,671 |
| 2023-04-13 | Sullivan Mark | General Counsel & Secretary | Award | 200,000 |
| 2023-04-13 | Sullivan Mark | General Counsel & Secretary | Other | 0 |
| 2023-03-14 | Barrow Robert | Director, Chief Executive Officer | Award | 400,000 |
| 2023-03-14 | Karlin Daniel | Chief Medical Officer | Award | 125,000 |